Libor Vitek is the Head of the Hepatological Laboratory of the Institute of Medical Biochemistry and Laboratory Diagnostics at the First Faculty of Medicine, Charles University, in Prague. He is also a Doctor-specialist at the 4th Internal Clinic of the General Faculty Hospital and First Faculty of Medicine in Prague and was appointed Associate Professor in Medical Chemistry and Biochemistry at the 1st Medical Faculty of Charles University in Prague in 2005. He obtained a Diploma at the 1st Medical Faculty of Charles University in Prague in 1994; completed postgraduate studies in Biochemistry at the First Faculty of Medicine, Charles University, in Prague in 2001; and obtained a Master of Business Administration in 2005. He has been a member of the Committee of the Czech Hepatology Society since 2010, a member of the Czech Gastroenterology Society, a member of the American Society Association for the Study of Liver Diseases (AASLD), and a member of the American Gastroenterology Association (AGA).
Claudio Tiribelli earned a degree in Medicine and Surgery from the University of Padua and specialized in Gastroenterology at the University of Trieste. He served as a Full Professor of Clinical Biochemistry from 1989 to 2008 and a Full Professor of Gastroenterology from 2009 to 2016. He is an expert hepatologist renowned for his research on bilirubin, particularly on kernicterus, a type of neurological damage caused by bilirubin in newborns. The founder and current Scientific Director of the Italian Liver Foundation-Onlus, located at AREA Science Park in Basovizza, an internationally recognized center for translational hepatological research and education, he has authored over 437 publications, with a total citation count of 24,486 and an h-index of 69 (Scopus).
Silvia Gazzin is a Senior Scientist at the Italian Liver Foundation-Onlus Liver Brain Unit "Rita Moretti". In 2006, she was a Visiting Researcher at INSERM, where she studied the blood–brain barrier. She has been at FIF since 2004, where, since 2011, she has performed the role of Senior Scientist, dealing mainly with two lines of research that investigate the opposite roles (toxic–neonatal vs. protective jaundice–Gilbert) of bilirubin on the brain. Thanks to collaboration with doctors involved in these diseases, the research is conducted with a translational approach, i.e., by the patient, through experimental models and molecular biology techniques, looking for new evidence with a useful relapse at a clinical level.
